Cargando…
Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature
The Xen gel stent (Allergan Inc, an AbbVie company; Dublin, Ireland) was conceived as an option for patients requiring modest IOP reduction but for whom trabeculectomy was not yet indicated. As with any glaucoma surgery, establishing criteria for patient selection and identifying factors that contri...
Autores principales: | Panarelli, Joseph F, Vera, Vanessa, Sheybani, Arsham, Radcliffe, Nathan, Fiscella, Richard, Francis, Brian A, Smith, Oluwatosin U, Noecker, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845068/ https://www.ncbi.nlm.nih.gov/pubmed/36660309 http://dx.doi.org/10.2147/OPTH.S390955 |
Ejemplares similares
-
Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation
por: Vera, Vanessa, et al.
Publicado: (2019) -
Intraoperative suprachoroidal hemorrhage during Xen gel stent implantation
por: Liu, James C., et al.
Publicado: (2020) -
XEN(®)-63 Compared to XEN(®)-45 Gel Stents to Reduce Intraocular Pressure in Glaucoma
por: Evers, Charlotte, et al.
Publicado: (2023) -
Comparison of Safety and Efficacy Between Ab Interno and Ab Externo Approaches to XEN Gel Stent Placement
por: Tan, Nicholas E, et al.
Publicado: (2021) -
XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
por: Panarelli, Joseph F., et al.
Publicado: (2020)